Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 50: 2157-2159, 2004; 10.1373/clinchem.2004.039594
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kellogg, M. D.
Right arrow Articles by Rifai, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kellogg, M. D.
Right arrow Articles by Rifai, N.
Related Collections
Right arrow Pediatric Clinical Chemistry
Right arrow Drug Monitoring and Toxicology
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2004;50:2157-2159.)
© 2004 American Association for Clinical Chemistry, Inc.

Technical Briefs

Rapid and Simple Tandem Mass Spectrometry Method for Determination of Serum Cotinine Concentration

Mark D. Kellogg1,a, Jasna Behaderovic1, Oneil Bhalala2 and Nader Rifai1

1 Department of Laboratory Medicine, Children’s Hospital, Harvard Medical School, Boston MA;2 Department of Mathematics, Massachusetts Institute of Technology, Cambridge, MA;

aaddress correspondence to this author at: Department of Laboratory Medicine, Children’s Hospital, Harvard Medical School, 300 Longwood Ave., Boston MA 02155; fax 617-730-0383, e-mail mark.kellogg@childrens.harvard.edu

The first 20% of the full text of this article appears below.

Tobacco use, primarily through cigarette smoking, continues to be a primary cause of preventable death worldwide. It has been well documented that exposure to tobacco smoke, which is very common, causes chronic lung and heart disease. Data from the 1988–1991 National Health and Nutrition Examination Survey data found that 87.9% of nonsmokers had detectable concentrations of serum cotinine (1). Because of the health risks associated with tobacco exposure, analysis of biomarkers of tobacco exposure has increased. Cotinine is the preferred serum biomarker for tobacco exposure (2)(3)(4)(5).

Nicotine, a natural product in tobacco, is rapidly absorbed through the lungs into the pulmonary venous circulation and then to the heart and other body organs. It has a biological half-life of only 1 h and is rapidly excreted in the urine. As such, its use to measure tobacco exposure is limited. Nicotine is metabolized primarily via oxidation of the {alpha}-carbon to cotinine and N-oxidation of the pyrrolidine ring (6)(7). Cotinine accounts for ~90% of nicotine metabolites in serum and has a half-life of 10–40 h (8)(9). This relatively longer half-life makes it suitable for assessing exposure to cigarette smoke.

Validated methods for cotinine analysis in passive smoke assessment generally require large sample volumes, which are unsuitable for pediatric populations. Available methods that use smaller sample volumes and/or less complex extractions do not provide adequate assay sensitivity, thus precluding their use in assessing passive cigarette smoke exposure (10). We describe the development of a sensitive single-step extraction and rapid method for serum cotinine based on ion spray tandem mass spectrometry (MS/MS).

. . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.